Novartis to sell nutrition unit to Nestle for €1.88 bln
Novartis AG, Europe's third-largest drugmaker, agreed to sell its medical nutrition unit to Nestle SA for €1.88 billion ($2.5 billion) to focus on medicines and vaccines.
The transaction should be completed in the H2 of next year, Novartis, the Basel, Switzerland-based company said in an e-mailed statement. The unit makes nutritional supplements used in hospitals and generates annual sales of about €715.8 million ($950 million).
„This divestment continues to enhance our focus on healthcare, further strengthens our financial position and provides strategic flexibility,” CEO Daniel Vasella said in the statement. Novartis sold its nutrition unit, which makes Isostar energy drinks, to ABN Amro Holding NV for €204 million ($271 million) in March. Another food division, known for the malt drink Ovaltine, was sold to Associated British Foods Plc at the end of 2002 for 398.6 million Swiss francs (€248.6 million). (Bloomberg)
SUPPORT THE BUDAPEST BUSINESS JOURNAL
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.